Nano Nuclear Energy (NNE) Financials

Nano Nuclear Energy (NASDAQ: NNE) remains a pre-revenue story with a very large cash balance, but the latest quarter shows continued heavy spending and persistent losses. Over the last several quarters, the company has scaled up its balance sheet dramatically, largely through equity issuance, while operating losses have widened as R&D and SG&A expenses increased.

• Very strong liquidity: As of Q2 2026, Nano Nuclear Energy reported about $569.0 million in cash, equivalents, and short-term investments combined, which gives it substantial financial flexibility.
• Minimal debt burden: Total liabilities were only about $8.0 million in Q2 2026, while total equity was about $595.9 million, leaving the balance sheet lightly levered.
• Cash runway improved materially: The company’s cash/investment base is far larger than it was a year ago, suggesting it has enough capital to keep funding development initiatives for some time.
• Operating cash use was modest relative to liquidity: Q2 2026 operating cash outflow was about $5.3 million, which is manageable against the current cash reserve.
• Investments and other assets remain on the balance sheet: Nano Nuclear also held long-term investments and a growing base of noncurrent assets, which adds some cushion to the asset base.
• No revenue yet: The company reported $0 revenue in every quarter shown, so the investment case still depends on future commercialization, not current sales.
• Research spending remains a priority: Q2 2026 R&D expense was $5.7 million, which is consistent with an early-stage development company but contributes to ongoing losses.
• Share count has been rising over time: Weighted average basic shares increased from roughly 23.2 million in Q1 2024 to 51.6 million in Q2 2026, reflecting significant dilution and capital raises.
• Losses are still wide: Q2 2026 net loss came in at about $9.2 million, and the company has reported losses in every quarter in the dataset.
• Quarterly losses have worsened versus early 2025: Net loss expanded from about $3.1 million in Q1 2025 to $9.2 million in Q2 2026.
• Operating expenses are trending higher: Combined SG&A and R&D spending rose to roughly $14.2 million in Q2 2026, up from about $11.6 million in Q1 2026 and well above prior-year levels.
• Investing cash outflow was very large in Q2 2026: The company reported about $377.4 million of net cash used in investing activities, which likely reflects major capital deployment and/or portfolio activity that investors should monitor closely.
• Dependence on financing remains high: Historical cash flow shows the company repeatedly relied on equity issuance and financing inflows to fund operations and development, which could continue to pressure existing shareholders.

Bottom line: Nano Nuclear Energy’s balance sheet is currently the bright spot. It has a large cash position, low debt, and enough capital to keep advancing its business. The downside is that it is still a pre-revenue company with persistent operating losses and meaningful dilution risk. For retail investors, the key question is not near-term profitability, but whether management can convert this capital into meaningful progress toward commercialization.